Last reviewed · How we verify
Idiopathic hypereosinophilic syndrome
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Idiopathic hypereosinophilic syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Idiopathic hypereosinophilic syndrome treatment landscape brief
- Idiopathic hypereosinophilic syndrome treatment updates RSS
Frequently asked questions about Idiopathic hypereosinophilic syndrome
What drugs treat Idiopathic hypereosinophilic syndrome?
Tracked treatments include Gleevec.
What is the treatment for Idiopathic hypereosinophilic syndrome?
Standard treatment for Idiopathic hypereosinophilic syndrome includes Gleevec. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Idiopathic hypereosinophilic syndrome patent cliff · Idiopathic hypereosinophilic syndrome CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Gleevec · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing